1. Home
  2. OGEN vs RVYL Comparison

OGEN vs RVYL Comparison

Compare OGEN & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • RVYL
  • Stock Information
  • Founded
  • OGEN 1996
  • RVYL 2007
  • Country
  • OGEN United States
  • RVYL United States
  • Employees
  • OGEN N/A
  • RVYL N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • RVYL Professional Services
  • Sector
  • OGEN Health Care
  • RVYL Consumer Discretionary
  • Exchange
  • OGEN Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • OGEN 9.8M
  • RVYL 13.7M
  • IPO Year
  • OGEN N/A
  • RVYL N/A
  • Fundamental
  • Price
  • OGEN $1.13
  • RVYL $1.86
  • Analyst Decision
  • OGEN
  • RVYL Hold
  • Analyst Count
  • OGEN 0
  • RVYL 1
  • Target Price
  • OGEN N/A
  • RVYL N/A
  • AVG Volume (30 Days)
  • OGEN 133.4K
  • RVYL 46.9K
  • Earning Date
  • OGEN 08-12-2024
  • RVYL 08-12-2024
  • Dividend Yield
  • OGEN N/A
  • RVYL N/A
  • EPS Growth
  • OGEN N/A
  • RVYL N/A
  • EPS
  • OGEN N/A
  • RVYL N/A
  • Revenue
  • OGEN $20,629.00
  • RVYL $71,352,000.00
  • Revenue This Year
  • OGEN N/A
  • RVYL $31.47
  • Revenue Next Year
  • OGEN N/A
  • RVYL N/A
  • P/E Ratio
  • OGEN N/A
  • RVYL N/A
  • Revenue Growth
  • OGEN N/A
  • RVYL 78.42
  • 52 Week Low
  • OGEN $0.97
  • RVYL $1.12
  • 52 Week High
  • OGEN $7.74
  • RVYL $17.50
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 40.50
  • RVYL 53.70
  • Support Level
  • OGEN $1.00
  • RVYL $1.95
  • Resistance Level
  • OGEN $1.19
  • RVYL $2.25
  • Average True Range (ATR)
  • OGEN 0.06
  • RVYL 0.22
  • MACD
  • OGEN 0.03
  • RVYL 0.03
  • Stochastic Oscillator
  • OGEN 57.41
  • RVYL 47.57

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks: